Epilepsy in the WHO South East Asian Region | Bridging the gap - who south east asian region

Category

who south east asian region - WHO | South-East Asian Region


Bangladesh, Bhutan, Nepal and Thailand have become the first countries in WHO South-East Asia Region to achieve Hepatitis B control, with prevalence of the deadly disease dropping to less than one per cent among five-year-old children. Cost effectiveness and strategic planning (WHO-CHOICE) Menu. Health economics; WHO-CHOICE. Generalized Cost-Effectiveness Analysis; WHO-CHOICE methods.

Noncommunicable diseases (NCDs) — mainly cardiovascular diseases, chronic respiratory diseases, diabetes and cancer — are top killers in the South-East Asia Region, claiming an estimated 8.5 million lives each year. One third of these deaths are premature and occur before the age of 70 years, thus affecting economically productive individuals. WHO South-East Asia Region (SEAR) 2014-2015. Cooperative agreements with ministries of health (MOH) or institutions designated by the MOH build capacity to routinely identify, diagnose and respond to seasonal, avian and pandemic influenza.

Epilepsy affects about 1% of the population of the South-East Asia Region of WHO thus there are approximately 15 million people with epilepsy in the Region. Despite global advances in modern medicine, epilepsy continues to be surrounded by myths and misconceptions. Southeast Asia, vast region of Asia situated east of the Indian subcontinent and south of China. It consists of two dissimilar portions: a continental projection (commonly called mainland Southeast Asia) and a string of archipelagoes to the south and east of the mainland (insular Southeast Asia).